Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS) against a Thai HP-PRRSV challenge.

Tropical animal health and production - 1 Oct 2018

Sirisereewan Chaitawat, Woonwong Yonlayong, Arunorat Jirapat, Kedkovid Roongtham, Nedumpun Teerawut, Kesdangsakonwut Sawang, Suradhat Sanipa, Thanawongnuwech Roongroje, Teankum Komkrich

Abstract excerpt

The Chinese highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) has caused a severe threat to the pig population in Southeast Asian countries. The purpose of this study was to investigate the efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS, lineage 7) against a Thai HP-PRRSV (10PL01, lineage 8). Three-week-old PRRSV-free pigs were randomly assigned into three groups....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Husbandry
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Porcine Reproductive and Respiratory Syndrome

Share to Porcine respiratory and reproductive syndrome virus

Share to Vaccination

Share to Vaccines, Attenuated

Share to Viral Vaccines

Share to Viremia

Source

Identifiers

PMID: 29696456
DOI: 10.1007/s11250-018-1589-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS) against a Thai HP-PRRSV challenge.PMID 29696456Read ↗

Efficacy of Type 2 PRRSV vaccine against Chinese and Vietnamese HP-PRRSV challenge in pigsSemantic proximity Read ↗

Current Status of Porcine Reproductive and Respiratory Syndrome VaccinesSemantic proximity Read ↗

An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRSSemantic proximity Read ↗

Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome VaccinesSemantic proximity Read ↗

Commercial PRRS Modified-Live Virus VaccinesSemantic proximity Read ↗

Genetic signatures of the immune-escaping type 2 porcine reproductive and respiratory syndrome virus in farms with a robust vaccination program.Semantic proximity Read ↗

Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV)Semantic proximity Read ↗

Immunity Against a Japanese Local Strain of Porcine Reproductive and Respiratory Syndrome Virus Decreases Viremia and Symptoms of a Highly Pathogenic StrainSemantic proximity Read ↗

Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A “Leaky” Vaccine with Debatable Efficacy and SafetySemantic proximity Read ↗

Efficacy evaluation of two commercial modified-live virus vaccines against a novel recombinant type 2 porcine reproductive and respiratory syndrome virusSemantic proximity Read ↗

Porcine Reproductive and Respiratory Syndrome Virus: Immune Escape and Application of Reverse Genetics in Attenuated Live Vaccine DevelopmentSemantic proximity Read ↗

Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.